Annual Operating Expenses
$191.80 M
-$31.98 M-14.29%
31 December 2023
Summary:
Vanda Pharmaceuticals annual total operating expenses is currently $191.80 million, with the most recent change of -$31.98 million (-14.29%) on 31 December 2023. During the last 3 years, it has fallen by -$5.77 million (-2.92%). VNDA annual operating expenses is now -14.29% below its all-time high of $223.77 million, reached on 31 December 2022.VNDA Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$56.10 M
-$1.79 M-3.09%
30 September 2024
Summary:
Vanda Pharmaceuticals quarterly total operating expenses is currently $56.10 million, with the most recent change of -$1.79 million (-3.09%) on 30 September 2024. Over the past year, it has increased by +$14.35 million (+34.38%). VNDA quarterly operating expenses is now -9.80% below its all-time high of $62.20 million, reached on 31 March 2022.VNDA Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VNDA Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -14.3% | +34.4% |
| 3 y3 years | -2.9% | +6.9% |
| 5 y5 years | +27.1% | +33.8% |
VNDA Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -14.3% | at low | -9.8% | +34.4% |
| 5 y | 5 years | -14.3% | +27.1% | -9.8% | +34.4% |
| alltime | all time | -14.3% | +1905.7% | -9.8% | +1045.1% |
Vanda Pharmaceuticals Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $56.10 M(-3.1%) |
| June 2024 | - | $57.89 M(+8.7%) |
| Mar 2024 | - | $53.26 M(+8.9%) |
| Dec 2023 | $191.80 M(-14.3%) | $48.91 M(+17.1%) |
| Sept 2023 | - | $41.75 M(-8.1%) |
| June 2023 | - | $45.42 M(-18.5%) |
| Mar 2023 | - | $55.72 M(+8.0%) |
| Dec 2022 | $223.77 M(+11.4%) | $51.62 M(-6.3%) |
| Sept 2022 | - | $55.09 M(+0.4%) |
| June 2022 | - | $54.87 M(-11.8%) |
| Mar 2022 | - | $62.20 M(+17.0%) |
| Dec 2021 | $200.89 M(+1.7%) | $53.15 M(+1.3%) |
| Sept 2021 | - | $52.48 M(+7.2%) |
| June 2021 | - | $48.96 M(+5.8%) |
| Mar 2021 | - | $46.30 M(-8.8%) |
| Dec 2020 | $197.56 M(+9.8%) | $50.79 M(+8.8%) |
| Sept 2020 | - | $46.67 M(-1.1%) |
| June 2020 | - | $47.19 M(-10.8%) |
| Mar 2020 | - | $52.92 M(+4.9%) |
| Dec 2019 | $179.89 M(+19.2%) | $50.46 M(+20.3%) |
| Sept 2019 | - | $41.94 M(-2.0%) |
| June 2019 | - | $42.80 M(-4.2%) |
| Mar 2019 | - | $44.69 M(+16.9%) |
| Dec 2018 | $150.87 M(-8.1%) | $38.22 M(+1.0%) |
| Sept 2018 | - | $37.83 M(-1.0%) |
| June 2018 | - | $38.22 M(+4.5%) |
| Mar 2018 | - | $36.59 M(-12.1%) |
| Dec 2017 | $164.14 M(+17.3%) | $41.63 M(-0.2%) |
| Sept 2017 | - | $41.73 M(+5.8%) |
| June 2017 | - | $39.45 M(-4.5%) |
| Mar 2017 | - | $41.32 M(+22.9%) |
| Dec 2016 | $139.88 M(+10.4%) | $33.63 M(+4.6%) |
| Sept 2016 | - | $32.15 M(-6.3%) |
| June 2016 | - | $34.32 M(-13.7%) |
| Mar 2016 | - | $39.78 M(-1.9%) |
| Dec 2015 | $126.65 M(+19.3%) | $40.57 M(+29.3%) |
| Sept 2015 | - | $31.38 M(+15.0%) |
| June 2015 | - | $27.27 M(-0.6%) |
| Mar 2015 | - | $27.43 M(+21.3%) |
| Dec 2014 | $106.13 M | $22.61 M(+45.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2014 | - | $15.53 M(-51.9%) |
| June 2014 | - | $32.27 M(-9.7%) |
| Mar 2014 | - | $35.72 M(+115.5%) |
| Dec 2013 | $55.08 M(-10.8%) | $16.57 M(+17.2%) |
| Sept 2013 | - | $14.14 M(+20.5%) |
| June 2013 | - | $11.73 M(-7.1%) |
| Mar 2013 | - | $12.63 M(-16.7%) |
| Dec 2012 | $61.78 M(+47.2%) | $15.17 M(+10.9%) |
| Sept 2012 | - | $13.68 M(-16.9%) |
| June 2012 | - | $16.46 M(+0.0%) |
| Mar 2012 | - | $16.46 M(+15.3%) |
| Dec 2011 | $41.98 M(+78.7%) | $14.28 M(+26.8%) |
| Sept 2011 | - | $11.26 M(+25.9%) |
| June 2011 | - | $8.94 M(+19.3%) |
| Mar 2011 | - | $7.49 M(+15.8%) |
| Dec 2010 | $23.49 M(-39.1%) | $6.47 M(-0.5%) |
| Sept 2010 | - | $6.50 M(+15.8%) |
| June 2010 | - | $5.62 M(+14.7%) |
| Mar 2010 | - | $4.90 M(-60.7%) |
| Dec 2009 | $38.58 M(-27.0%) | $12.48 M(+69.6%) |
| Sept 2009 | - | $7.36 M(-39.6%) |
| June 2009 | - | $12.18 M(+85.8%) |
| Mar 2009 | - | $6.56 M(-14.3%) |
| Dec 2008 | $52.85 M(-34.0%) | $7.65 M(-31.6%) |
| Sept 2008 | - | $11.19 M(-19.7%) |
| June 2008 | - | $13.94 M(-30.5%) |
| Mar 2008 | - | $20.06 M(-9.0%) |
| Dec 2007 | $80.04 M(+21.8%) | $22.05 M(-6.3%) |
| Sept 2007 | - | $23.52 M(+33.3%) |
| June 2007 | - | $17.64 M(+4.9%) |
| Mar 2007 | - | $16.83 M(+35.6%) |
| Dec 2006 | $65.71 M(+170.6%) | $12.41 M(-3.1%) |
| Sept 2006 | - | $12.81 M(-42.0%) |
| June 2006 | - | $22.08 M(+19.9%) |
| Mar 2006 | - | $18.41 M(+160.9%) |
| Dec 2005 | $24.29 M(+154.0%) | $7.06 M(+22.6%) |
| Sept 2005 | - | $5.76 M(+4.0%) |
| June 2005 | - | $5.53 M(-6.8%) |
| Mar 2005 | - | $5.94 M |
| Dec 2004 | $9.56 M | - |
FAQ
- What is Vanda Pharmaceuticals annual total operating expenses?
- What is the all time high annual operating expenses for Vanda Pharmaceuticals?
- What is Vanda Pharmaceuticals annual operating expenses year-on-year change?
- What is Vanda Pharmaceuticals quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Vanda Pharmaceuticals?
- What is Vanda Pharmaceuticals quarterly operating expenses year-on-year change?
What is Vanda Pharmaceuticals annual total operating expenses?
The current annual operating expenses of VNDA is $191.80 M
What is the all time high annual operating expenses for Vanda Pharmaceuticals?
Vanda Pharmaceuticals all-time high annual total operating expenses is $223.77 M
What is Vanda Pharmaceuticals annual operating expenses year-on-year change?
Over the past year, VNDA annual total operating expenses has changed by -$31.98 M (-14.29%)
What is Vanda Pharmaceuticals quarterly total operating expenses?
The current quarterly operating expenses of VNDA is $56.10 M
What is the all time high quarterly operating expenses for Vanda Pharmaceuticals?
Vanda Pharmaceuticals all-time high quarterly total operating expenses is $62.20 M
What is Vanda Pharmaceuticals quarterly operating expenses year-on-year change?
Over the past year, VNDA quarterly total operating expenses has changed by +$14.35 M (+34.38%)